Europe Bioresorbable Vascular Scaffold Market Size, Share & Trends Analysis Report By Application (Peripheral Artery, Coronary Artery), By End Use, By Region, And Segment Forecasts, 2022 - 2030

September 2022 | 120 pages | ID: E88CCD155EE2EN
Grand View Research, Inc.

Abstracts

This report can be delivered to the clients within 4 Business Days

Europe Bioresorbable Vascular Scaffold Market Growth & Trends

The Europe bioresorbable vascular scaffold market size is expected to reach a value of USD 103.45 million by 2030. The market is anticipated to expand at a CAGR of 8.9% from 2022 to 2030. Factors such as the increasing percutaneous coronary intervention (PCI) procedures and the rising aging population are expected to drive growth. Technological advancements and the launch of devices are further fueling the growth of the industry. For instance, Meril Life Sciences, an Indian company, became the first to gain the European Conformity marking for their 'MeRes100' bioresorbable scaffold or dissolvable polymer stents in August 2019.

The global COVID-19 pandemic has negatively impacted the growth of the industry. During the pandemic, government orders requiring individuals to stay inside or take precautions to decrease their exposure resulted in the postponing of elective surgeries. Total PCI operation volumes thus decreased significantly in 2020. As a result, sales of bioresorbable vascular scaffold units diminished. As upliftment in covid restrictions drives individuals to use healthcare facilities and resumption in all semi-elective to non-urgent treatments at full capacity, these revenues are anticipated to accelerate.

Besides, factors such as initiatives undertaken by market players, and government support will continue to spur growth. For instance, in January 2019, Reva Medical expanded its commercial operations to seven (Poland, Russia, Slovakia, Lithuania, the Czech Republic, Latvia, and Estonia) additional European countries through four new regional distribution partnerships. Additionally, the market expansion in Europe is mostly attributable to rising regulatory approvals, which would facilitate their commercialization, and expand opportunities for the development of bioresorbable scaffolds.

Europe Bioresorbable Vascular Scaffold Market Report Highlights

• New-generation BRSs to supply thinner struts and smaller crossing profiles led to the market expansion despite initial setbacks, such as overcoming the clinical shortcomings associated with the Absorb BRS constituting a technological barrier
• Coronary artery/vascular stent held the dominant share in 2021. This is attributed to rising cardiovascular disorders in the region. According to the European Heart Network, cardiovascular disease (CVD) results in about 1.8 million fatalities in the European Union and 3.9 million deaths overall in Europe each year
• Hospitals held the dominant share of over 98.0% as of 2021. As hospitals offer superior care to patients thus witnessing lucrative growth. Hospitals are important within the overall healthcare system and the main revenue source for the entire sector, which drives segment growth
• Due to growing public awareness of PCI treatment, France held the majority of the market in 2021 with a revenue share of over 15%. The prevalence of CAD across the country also contributes to the market's expansion. One fatality occurs every four minutes in France due to cardiac artery disease, which affects 1.5 million individuals and is the leading cause of all-cause mortality
• The market scenario is changing as it is gradually fragmenting owing to the entrance of new players. For instance, in May 2021, a study of patients with comparatively simple coronary artery lesions discovered some early promise for a novel bioresorbable scaffold (Firesorb, MicroPort Medical)

Contents

CHAPTER 1 RESEARCH METHODOLOGY & SCOPE

1.1 Market Segmentation & Scope
  1.1.1 Segment Scope
  1.1.2 Regional Scope
  1.1.3 Estimates & Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
  1.3.1 Purchased Database:
  1.3.2 GVR’s Internal Database
  1.3.3 Secondary Sources
  1.3.4 Primary Research:
  1.3.5 Details of Primary Research
1.4 Information or Data Analysis
  1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Abbreviations
1.10 Objectives
  1.10.1 Objective 1:
  1.10.2 Objective 2:
1.11 Market Definitions

CHAPTER 2 EXECUTIVE SUMMARY

2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Outlook

CHAPTER 3 EUROPE BIORESORBABLE VASCULAR SCAFFOLD MARKET VARIABLES TRENDS & SCOPE

3.1 Market Lineage Outlook
  3.1.1 Parent Market Outlook
  3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Regulatory Framework
3.4 Market Dynamics
  3.4.1 Market Driver Analysis
  3.4.2 Market Restraints Analysis
  3.4.3 Market Opportunity Analysis
  3.4.3 Market Challenges Analysis
3.5 Industry Analysis - Porter’s
3.6 Europe Bioresorbable Vascular Scaffold - PESTLE Analysis
3.7 Product Pipeline Analysis
  3.7.1 Clinical Trial Data
  3.7.2 Estimated Product Launch
3.8 Patent Analysis
3.9 Pricing Analysis
3.10 Estimated Procedure Volume Data, By Country, 2017 - 2030
3.11 Estimated Unit Volume Data, By Country, 2017 - 2030
3.12 Estimated ASP, By Country, 2017 - 2030
3.13 Covid-19 Impact Analysis
  3.13.1 Current & Future Impact Analysis
  3.13.2 Impact on market players

CHAPTER 4 EUROPE BIORESORBABLE VASCULAR SCAFFOLD MARKET: COMPETITIVE ANALYSIS

4.1 Market Participation Categorization
4.2 Company Market Position Analysis
4.3 Major Deals & Strategic Alliances

CHAPTER 5 EUROPE BIORESORBABLE VASCULAR SCAFFOLD MARKET: APPLICATION ANALYSIS

5.1 Application Business Analysis
  5.1.1 Peripheral Artery
    5.1.1.1 Market estimates and forecasts, 2017 - 2030 (USD Million)
  5.1.2 Coronary Artery
    5.1.2.1 Market estimates and forecasts, 2017 - 2030 (USD Million)

CHAPTER 6 EUROPE BIORESORBABLE VASCULAR SCAFFOLD MARKET: END-USE ANALYSIS

6.1 End-Use Business Analysis
  6.1.1 Hospitals & Clinics
    6.1.1.1 Market estimates and forecasts, 2017 - 2030 (USD Million)
  6.1.2 Others
    6.1.2.1 Market estimates and forecasts, 2017 - 2030 (USD Million)

CHAPTER 7 EUROPE BIORESORBABLE VASCULAR SCAFFOLD MARKET: REGIONAL MARKET ANALYSIS, BY APPLICATION, AND END-USE 2017 - 2030 (USD MILLION)

7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2021 & 2030
7.3 Regional Market Snapshot
7.4 Market Size, & Forecasts, Volume and Trend Analysis, 2017 to 2030
  7.4.2 Europe
    7.4.2.1 Europe Bioresorbable Vascular Scaffold market estimates and forecasts by countries, 2017 - 2030 (USD Million)
    7.4.2.2 U.K.
      7.4.2.2.1 U.K. Bioresorbable Vascular Scaffold market estimates and forecasts, 2017 - 2030 (USD Million)
    7.4.2.3 Germany
      7.4.2.3.1 Germany Bioresorbable Vascular Scaffold market estimates and forecasts, 2017 - 2030 (USD Million)
    7.4.2.4 France
      7.4.2.4.1 France Bioresorbable Vascular Scaffold market estimates and forecasts, 2017 - 2030 (USD Million)
    7.4.2.5 Italy
      7.4.2.5.1 Italy Bioresorbable Vascular Scaffold market estimates and forecasts, 2017 - 2030 (USD Million)
    7.4.2.6 Spain
      7.4.2.6.1 Spain Bioresorbable Vascular Scaffold market estimates and forecasts, 2017 - 2030 (USD Million)
    7.4.2.7 Switzerland
      7.4.2.7.1 Switzerland Bioresorbable Vascular Scaffold market estimates and forecasts, 2017 - 2030 (USD Million)
    7.4.3.8 Sweden
      7.4.3.8.1 Sweden Bioresorbable Vascular Scaffold market estimates and forecasts, 2017 - 2030 (USD Million)
    7.4.3.9 Belgium
      7.4.3.9.1 Belgium Bioresorbable Vascular Scaffold market estimates and forecasts, 2017 - 2030 (USD Million)
    7.4.3.10 The Netherlands
      7.4.3.10.1 The Netherlands Bioresorbable Vascular Scaffold market estimates and forecasts, 2017 - 2030 (USD Million)

CHAPTER 8 COMPANY PROFILES

8.1 Reva Medical
  8.1.1 Company Overview
  8.1.2 Financial Performance
  8.1.3 Product Benchmarking
  8.1.4 Strategic Initiatives
8.2 Elixir Medical
  8.2.1 Company Overview
  8.2.2 Financial Performance
  8.2.3 Product Benchmarking
  8.2.4 Strategic Initiatives
8.3 Arterial Remodelling Technologies
  8.3.1 Company Overview
  8.3.2 Financial Performance
  8.3.3 Product Benchmarking
  8.3.4 Strategic Initiatives
8.4 Meril Life Sciences
  8.4.1 Company Overview
  8.4.2 Financial Performance
  8.4.3 Product Benchmarking
  8.4.4 Strategic Initiatives
8.5 Biotronik
  8.5.1 Company Overview
  8.5.2 Financial Performance
  8.5.3 Product Benchmarking
  8.5.4 Strategic Initiatives

List Of Tables

LIST OF TABLES

Table 1 List of primary sources
Table 2 List of secondary sources
Table 3 Estimated Procedure Volume Data, By Country, 2017 - 2030
Table 4 Estimated Unit Volume Data, By Country, 2017 - 2030
Table 5 Estimated ASP, By Country, 2017 - 2030
Table 6 Europe Bioresorbable Vascular Scaffold market, by applications, 2017 - 2030 (USD Million)
Table 7 Europe Bioresorbable Vascular Scaffold market, by end-use, 2017 - 2030 (USD Million)
Table 8 U.K. Bioresorbable Vascular Scaffold market, by applications, 2017 - 2030 (USD Million)
Table 9 U.K. Bioresorbable Vascular Scaffold market, by end-use, 2017 - 2030 (USD Million)
Table 10 Germany Bioresorbable Vascular Scaffold market, by applications, 2017 - 2030 (USD Million)
Table 11 Germany Bioresorbable Vascular Scaffold market, by end-use, 2017 - 2030 (USD Million)
Table 12 France Bioresorbable Vascular Scaffold market, by applications, 2017 - 2030 (USD Million)
Table 13 France Bioresorbable Vascular Scaffold market, by end-use, 2017 - 2030 (USD Million)
Table 14 Italy Bioresorbable Vascular Scaffold market, by applications, 2017 - 2030 (USD Million)
Table 15 Italy Bioresorbable Vascular Scaffold market, by end-use, 2017 - 2030 (USD Million)
Table 16 Spain Bioresorbable Vascular Scaffold market, by applications, 2017 - 2030 (USD Million)
Table 17 Spain Bioresorbable Vascular Scaffold market, by end-use, 2017 - 2030 (USD Million)
Table 18 Switzerland Bioresorbable Vascular Scaffold market, by applications, 2017 - 2030 (USD Million)
Table 19 Switzerland Bioresorbable Vascular Scaffold market, by end-use, 2017 - 2030 (USD Million)
Table 20 Sweden Bioresorbable Vascular Scaffold market, by applications, 2017 - 2030 (USD Million)
Table 21 Sweden Bioresorbable Vascular Scaffold market, by end-use, 2017 - 2030 (USD Million)
Table 22 Belgium Bioresorbable Vascular Scaffold market, by applications, 2017 - 2030 (USD Million)
Table 23 Belgium Bioresorbable Vascular Scaffold market, by end-use, 2017 - 2030 (USD Million)
Table 24 The Netherland Bioresorbable Vascular Scaffold market, by applications, 2017 - 2030 (USD Million)
Table 25 The Netherland Bioresorbable Vascular Scaffold market, by end-use, 2017 - 2030 (USD Million)

List Of Figures

LIST OF FIGURES

Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Primary interviews in Europe
Fig. 6 Market research approaches
Fig. 7 Value-chain-based sizing & forecasting
Fig. 8 QFD modeling for market share assessment
Fig. 9 Market formulation & validation
Fig. 10 Europe Bioresorbable Vascular Scaffold market snapshot
Fig. 11 Penetration & growth prospect mapping
Fig. 12 Technology impact analysis
Fig. 13 Europe Bioresorbable Vascular Scaffold market dynamics
Fig. 14 Europe Bioresorbable Vascular Scaffold market driver impact
Fig. 15 Europe Bioresorbable Vascular Scaffold market restraint impact
Fig. 16 Market participant categorization
Fig. 17 Company market position analysis
Fig. 18 Company market share analysis
Fig. 19 Europe Bioresorbable Vascular Scaffold market: Application movement analysis
Fig. 20 Europe Bioresorbable Vascular Scaffold Application dashboard
Fig. 21 Peripheral Artery market, 2017 - 2030 (USD Million)
Fig. 22 Coronary Artery market, 2017 - 2030 (USD Million)
Fig. 23 Europe Bioresorbable Vascular Scaffold market: End-Use movement analysis
Fig. 24 Europe Bioresorbable Vascular Scaffold End-Use dashboard
Fig. 25 Hospitals & Clinics market, 2017 - 2030 (USD Million)
Fig. 26 Others market, 2017 - 2030 (USD Million)
Fig. 27 Regional marketplace: Key takeaways
Fig. 28 Europe Bioresorbable Vascular Scaffold market, 2017 - 2030 (USD Million)
Fig. 29 UK Europe Bioresorbable Vascular Scaffold market, 2017 - 2030 (USD Million)
Fig. 30 Germany Europe Bioresorbable Vascular Scaffold market, 2017 - 2030 (USD Million)
Fig. 31 France Europe Bioresorbable Vascular Scaffold market, 2017 - 2030 (USD Million)
Fig. 32 Italy Europe Bioresorbable Vascular Scaffold market, 2017 - 2030 (USD Million)
Fig. 33 Spain Europe Bioresorbable Vascular Scaffold market, 2017 - 2030 (USD Million)
Fig. 34 The Netherlands Europe Bioresorbable Vascular Scaffold market, 2017 - 2030 (USD Million)
Fig. 35 Sweden Bioresorbable Vascular Scaffold market, 2017 - 2030 (USD Million)
Fig. 36 Belgium Bioresorbable Vascular Scaffold market, 2017 - 2030 (USD Million)
Fig. 37 Switzerland Bioresorbable Vascular Scaffold market, 2017 - 2030 (USD Million)